Biochemical characterization of human and yeast choline and ethanolamine kinases  [QD415. S451 2006 f rb]. by See, Too Wei Cun
  
 
 
 
 
BIOCHEMICAL CHARACTERIZATION OF 
HUMAN AND YEAST 
CHOLINE AND ETHANOLAMINE KINASES 
 
 
 
 
 
 
 
by 
 
 
 
 
 
 
SEE TOO WEI CUN 
 
 
 
 
 
 
 
 
 
Thesis submitted in fulfilment of the 
requirements for the degree of 
Doctor of Philosophy 
 
 
 
 
 
 
 
April 2006 
 
 
 
 ii 
ACKNOWLEDGMENTS 
 
I would like to thank my field supervisor, Dr. Manfred Konrad for his scientific guidance 
and his trust in me by giving me the independence to fulfill my curiosity in science. I am 
also very indebted to his enormous help during the preparation of this thesis and his 
kind hospitality, which has really enhanced the joy of my stay in Germany. 
 
I would also like to express my sincere appreciation to Associate Professor Dr. Tengku 
Sifzizul bin Tengku Muhammad for his willingness to act as my formal supervisor and 
his invaluable help on many occasions. I am also grateful to Professor Dieter Gallwitz 
for giving me the opportunity to work in his department and Professor Zainul 
Fadziruddin Zainuddin, Professor Norazmi Mohd. Nor and Associate Professor Dr. 
Nazalan Najimudin for their advice and assistance. 
 
I would like to acknowledge the contributions of Dr. Enrico Malito, Nikolina Sekulic and 
Associate Professor Dr. Arnon Lavie in solving the structure of human choline kinase. I 
thank Dr. Henning Urlaub and Dr. Jens Grüber for their help in protein mass 
spectrometry and RNAi experiments. 
 
I am very thankful to Universiti Sains Malaysia for its generous financial support under 
the Academic Staff Training Scheme and staffs from Institute for Postgraduate Studies 
for their help in all aspects of my Ph.D candidature. 
 
A very big ‘’Thank you’’ to all my former collegues in Germany, especially to Stephan, 
Heike, Ursula, and Yujie for their friendships that made the three years of my life in 
Göttingen so special. Last but not least, I thank my wife Ling Ling, and my family for 
their love and support. 
 iii 
 
 
 
 
 
 
 
This thesis is dedicated to my wife Ling Ling, 
for her patience and unwavering support, 
and our son Zhi Xiang, 
my source of inspiration and fascination. 
 iv 
TABLE OF CONTENTS 
 
 
 
ACKNOWLEDGEMENTS 
 
TABLE OF CONTENTS 
 
LIST OF TABLES 
 
LIST OF FIGURES 
 
LIST OF PLATES 
 
LIST OF ABBREVIATIONS 
 
ABSTRAK 
 
ABSTRACT 
 
 
 
CHAPTER 1.0 INTRODUCTION 
 
1.1 Phospholipids: Structures and functions 
 
     1.1.1 Phosphatidic acid 
 
     1.1.2 Phosphatidylcholine 
 
     1.1.3 Phosphatidylethanolamine 
 
     1.1.4 Phosphatidylserine 
 
     1.1.5 Phosphatidylglycerol 
 
     1.1.6 Diphosphatidylglycerol 
 
     1.1.7 Inositol-containing phospholipids 
 
     1.1.8 Sphingophospholipids 
 
1.2 Biosynthesis of major eukaryotic membrane phospholipids: PA, PE,      
      PC and PS 
 
     1.2.1 Synthesis of the backbone, phosphatidic acid 
 
     1.2.2 Synthesis of phosphatidylcholine 
 
              1.2.2.1 CDP-choline pathway 
 
              1.2.2.2 Phosphatidylethanolamine methylation pathway 
 
     1.2.3 Synthesis of phosphatidylethanolamine 
Page 
 
ii 
 
iv 
 
xiii 
 
xiv 
 
xvi 
 
xix 
 
xxii 
 
xxiv 
 
 
 
1 
 
1 
 
5 
 
5 
 
6 
 
7 
 
7 
 
8 
 
8 
 
9 
 
9 
 
 
11 
 
13 
 
13 
 
14 
 
14 
 v 
              1.2.3.1 CDP-ethanolamine pathway 
 
              1.2.3.2 Phosphatidylserine decarboxylation pathway 
 
     1.2.4 Synthesis of Phosphatidylserine 
 
1.3 Choline kinase (CK) and ethanolamine kinase (EK) 
 
     1.3.1 Purification and substrate specificity of choline/ethanolamine kinase 
 
     1.3.2 Molecular cloning of eukaryotic choline kinase 
 
     1.3.3 Molecular cloning of eukaryotic ethanolamine kinase 
 
     1.3.4 Features of the choline/ethanolamine kinase amino acid sequences 
 
     1.3.5 Regulation of choline kinase activity 
 
1.4 Choline kinase in mitogenesis and cancer development 
 
     1.4.1 Phosphocholine as putative second messenger in regulation of   
              mitogenesis 
 
     1.4.2 Choline kinase inhibitors as potential anticancer drugs 
 
1.5 Ethanolamine kinase in regulation of cell survival 
 
1.6 Inhibition of choline kinase as potential treatment of other diseases 
 
1.7 Aims of the present study 
 
 
 
CHAPTER 2.0 MATERIALS AND METHODS 
 
2.1 Materials 
 
      2.1.1 Chemicals 
 
      2.1.2 Enzymes 
 
      2.1.3 Kits 
 
      2.1.4 Consumables 
 
      2.1.5 General instruments 
 
      2.1.6 Escherichia coli strain 
 
      2.1.7 Yeast species 
 
      2.1.8 Mammalian cell line 
 
      2.1.9 Plasmids 
 
15 
 
15 
 
16 
 
16 
 
18 
 
20 
 
25 
 
26 
 
28 
 
33 
 
35 
 
 
36 
 
38 
 
39 
 
41 
 
 
 
44 
 
44 
 
44 
 
45 
 
45 
 
45 
 
46 
 
46 
 
48 
 
48 
 
48 
 
 vi 
      2.1.10 Oligonucleotides 
 
      2.1.11 siRNA duplexes 
 
      2.1.12 Culture media 
 
                 2.1.12.1 Bacterial culture medium 
 
                 2.1.12.2 Yeast culture medium 
 
                 2.1.12.3 Mammalian cell culture medium 
 
      2.1.13 General buffers 
 
      2.1.14 Human liver cDNA library 
 
      2.1.15 Human normal/tumor protein array 
 
      2.1.16 Software for sequence analysis and other bioinformatic applications 
 
2.2 General methods 
 
      2.2.1 Sterilization techniques 
 
      2.2.2 Maintenance and revival of E. coli and yeast cells 
 
      2.2.3 Cell passage, freezing and revival of mammalian cell 
 
      2.2.4 Isolation of nucleic acids 
 
               2.2.4.1 E. coli plasmid purification (Miniprep and midiprep) 
 
               2.2.4.2 Agarose gel electrophoresis 
 
               2.2.4.3 DNA extraction from agarose gel 
 
               2.2.4.4 Genomic DNA extraction from yeast species (S. cerevisiae,  
                           S. pombe and A. gossypii) 
 
               2.2.4.5 Determination of DNA and RNA concentration 
 
      2.2.5 Modifications and manipulations of nucleic acids 
 
               2.2.5.1 DNA digestion with restriction enzymes 
 
               2.2.5.2 Ligation reaction 
 
               2.2.5.3 Dephosphorylation of DNA ends 
 
      2.2.6 Preparation of E. coli competent cells for heat shock  
               transformation 
 
      2.2.7 Heat shock transformation of E. coli cells 
 
      2.2.8 Amplification and plasmid purification of human liver cDNA  
               library 
48 
 
48 
 
56 
 
56 
 
56 
 
56 
 
56 
 
57 
 
57 
 
57 
 
57 
 
57 
 
59 
 
59 
 
60 
 
60 
 
61 
 
61 
 
61 
 
 
62 
 
62 
 
62 
 
63 
 
63 
 
63 
 
 
63 
 
64 
 vii 
      2.2.9   DEPC (diethylpyrocarbonate) treatment of solutions 
 
      2.2.10 Polymerase chain reaction (PCR) 
 
      2.2.11 TOPO-TA cloning of PCR product 
 
      2.2.12 Determination of protein concentration 
 
      2.2.13 Protein gel electrophoresis 
 
      2.2.14 Western Blotting 
 
      2.2.15 Protein expression and purification from E. coli 
 
                 2.2.15.1 Purification of GST-tagged protein 
 
                 2.2.15.2 Purification of Histidine-tagged and MBP-tagged  
                               proteins 
 
      2.2.16 Spectrophotometric assay of choline and ethanolamine kinase  
                 activities 
 
                 2.2.16.1 Analysis of kinetic data 
 
      2.2.17 Isotopic assay of choline and ethanolamine kinase activites 
 
2.3 Nomenclatures of human and yeasts choline and ethanolamine  
      kinases 
 
2.4 Cloning of human and yeasts CK/EKs 
 
2.5 Site directed mutagenesis by PCR 
 
2.6 Inhibition studies of hCK/EKs and yCK/EK 
 
2.7 In vitro phosphorylation of human choline and ethanolamine kinases 
 
      2.7.1 Phosphoprotein detection by phosphoprotein gel staining 
 
      2.7.2 Phosphoprotein detection by autoradiography 
 
      2.7.3 Determination of phosphorylation sites 
 
2.8 Production of antibody against hCKα2 
 
      2.8.1 Purification of antigen by SDS-PAGE 
 
      2.8.2 Antibody production 
       
      2.8.3 Sensitivity and specificity testing of hCKα2 antiserum 
 
2.9 Detection of hCKα on human normal/tumor tissue panel 
 
 
 
64 
 
64 
 
65 
 
66 
 
66 
 
68 
 
70 
 
70 
 
73 
 
 
77 
 
 
79 
 
79 
 
80 
 
 
80 
 
82 
 
83 
 
83 
 
84 
 
85 
 
85 
 
86 
 
86 
 
86 
 
86 
 
87 
 
 
 
 viii 
2.10 siRNA techniques 
 
        2.10.1 Design of siRNA sequences for targeting hCKα and β mRNAs 
 
        2.10.2 Preparation of siRNA duplexes 
 
        2.10.3 Preparation of cells before transfection 
 
        2.10.4 Transfection of HeLa cells with siRNA duplexes 
 
        2.10.5 Detection of siRNA-mediated silencing of hCKα 
 
                   2.10.5.1 Western blot detection of hCKα 
 
                   2.10.5.2 Immunofluorescence detection of hCKα 
 
        2.10.6 Detection of siRNA mediated silencing of hCKβ 
 
                   2.10.6.1 Total RNA purification from HeLa cells 
 
                   2.10.6.2 RT-PCR reaction 
 
 
 
CHAPTER 3.0 RESULTS 
 
3.1 Cloning, expression and purification of human and yeast  
      choline/ethanolamine kinases 
 
      3.1.1 Cloning and expression of the hCKα2 isoform 
 
      3.1.2 Construction of the hCKα1 isoform and its expression in bacteria 
 
      3.1.3 Cloning and expression of the hCKβ isoform 
 
      3.1.4 Cloning and expression of the hEK1 isoform 
 
      3.1.5 Cloning and expression of the hEK2α isoform 
 
               3.1.5.1 hEK2 gene structure analysis 
 
               3.1.5.2 Cloning and expression of the hEK2α 
 
      3.1.6 Cloning and expression of the hEK2β isoform 
 
      3.1.7 Cloning and expression of the yCK 
 
      3.1.8 Cloning and expression of the yEK 
 
      3.1.9 Cloning and expression of SpCK 
 
      3.1.10 Cloning and expression of the AgCK 
 
3.2 Amino acid sequence comparison of human and yeast CK/EKs 
88 
 
88 
 
88 
 
89 
 
89 
 
90 
 
90 
 
91 
 
92 
 
92 
 
92 
 
 
 
94 
 
94 
 
 
94 
 
95 
 
98 
 
101 
 
105 
 
105 
 
108 
 
111 
 
115 
 
120 
 
120 
 
123 
 
123 
 ix 
3.3 Characterization of human and yeast CK/EKs 
 
      3.3.1 Effect of temperature on the activity of hCK/EK isoforms 
 
      3.3.2 Effect of pH on the activity of hCK/EKs 
 
      3.3.3 Enzymatic assays of hCK/EKs 
 
      3.3.4 Activity assays of yeast CK/EKs 
 
      3.3.5 Comparison of human and yeast CK/EK catalytic properties 
 
      3.3.6 The W344A point mutation of hEK2α resulted in significantly lower  
               catalytic activity, and the ∆46C deletion mutation of hEK2α resulted    
               in loss of activity 
 
      3.3.7 Testing of different phosphoryl donors for hCK/EK isoforms 
 
3.4 Effect of Hemicholinium-3 (HC-3) inhibition on the activity of human  
      and yeast CK/EKs 
 
3.5 Identification of critical catalytic residues of human and yeast CK/EKs 
 
      3.5.1 Purification and enzymatic assays of hCKα2 mutant constructs 
 
      3.5.2 Mutation of the critical aspartate residue corresponding to D330 of  
               hCKα2 in hCKβ, ∆89N-hEK1 and yCK 
 
3.6 Identification of critical residues for ethanolamine specificity in ∆89N- 
      hEK1 
 
3.7 In vitro phosphorylation of hCK and EK isoforms 
 
      3.7.1 Prediction of potential hCK/EKs phosphorylating protein kinases 
 
      3.7.2 In vitro phosphorylation of hCK/EKs with protein kinase A (PKA) 
 
      3.7.3 Determination and confirmation of PKA phosphorylation sites in  
               hCKβ 
 
      3.7.4 In vitro phosphorylation of hCK/EKs with Protein Kinase C (PKC) 
 
      3.7.5 In vitro phosphorylation of hCK/EKs with Casein Kinase II (CK II) 
 
      3.7.6 Effect of PKA phosphorylation on hCKβ 
 
      3.7.7 Effect of PKC phosphorylation on hEK2α 
 
      3.7.8 PKA phosphorylation mimicry in hCKβ 
 
3.8 Raising and testing of hCKα2-specific antibody 
 
      3.8.1 Production of antibodies against hCK2α in rabbits 
 
127 
 
127 
 
130 
 
130 
 
136 
 
140 
 
142 
 
 
 
144 
 
146 
 
 
149 
 
150 
 
154 
 
 
157 
 
 
162 
 
162 
 
162 
 
167 
 
 
170 
 
173 
 
173 
 
175 
 
175 
 
177 
 
177 
 
 x 
      3.8.2 Western blot detection of purified hCKα2 by different dilutions of  
               antiserum 
 
      3.8.3 Cross reaction of hCKα2 antiserum with other hCK/EK isoforms 
 
      3.8.4 Specificity of hCKα2 antiserum in HeLa cell extract 
 
      3.8.5 Cross-reactivity of hCKα2 antiserum with mouse choline kinase 
 
3.9 Determination of hCKα isoform expression profile in different  
      tissues 
 
3.10 Gene silencing of hCKα and hCKβ isoforms by RNA interference 
 
        3.10.1 Design of hCKα and hCKβ isoform-specific duplex siRNA 
 
        3.10.2 Effect of hCKα and β silencing 
 
        3.10.3 Effect of hCKα and β siRNAs using different combination ratios 
 
        3.10.4 Confirmation of hCKα silencing by Western Blot 
 
        3.10.5 Confirmation of hCKα silencing by immunofluorescence detection 
 
        3.10.6 Silencing of hCKβ in β and α/β siRNA- treated cells demonstrated  
                   by RT-PCR 
 
        3.10.7 Subcellular localization of hCKα detected by immunofluorescence 
 
 
 
CHAPTER 4.0 DISCUSSION 
 
4.1 Different isoforms of human and yeast choline/ethanolamine kinases 
 
      4.1.1 Cloning and expression of hCK isoforms 
 
      4.1.2 Cloning and expression of hEK isoforms 
 
      4.1.3 Cloning and expression of yeast CK/EKs 
 
4.2 Biochemical characterizations of human and yeast CK/EKs 
 
      4.2.1 Enzyme-coupled spectrophotometric assay as an efficient way to  
               assay choline and ethanolamine kinase activity 
 
      4.2.2 hCK/EKs showed maximum activity at temperatures between 40 to  
               45°C 
 
      4.2.3 hCK/EKs showed alkali pH optimum typical of the CK/EK enzyme  
               family 
 
      4.2.4 Kinetic parameters of hCK/EK isoforms revealed their distinct  
               substrate preferences and catalytic properties 
181 
 
 
181 
 
184 
 
187 
 
187 
 
 
192 
 
193 
 
193 
 
196 
 
196 
 
199 
 
199 
 
 
202 
 
 
 
205 
 
205 
 
207 
 
208 
 
213 
 
214 
 
214 
 
 
215 
 
 
216 
 
 
216 
 
 xi 
      4.2.5 Saccharomyces cerevisiae ethanolamine kinase (yEK) is not specific  
               for ethanolamine 
 
      4.2.6 yCK and yEK evolved from a single choline specific kinase 
 
      4.2.7 hEKs showed broader specificity of phosphoryl donors than hCKs 
 
4.3 Hemicholinium-3 (HC-3) showed different inhibitory effects on  
      multiple isoforms of hCK/EKs and yCK/EKs 
 
4.4 Identification of critical residues for catalysis and substrate  
      specificity in hCK/EKs 
 
      4.4.1 Conserved aspartate 330 of hCKα2 and the corresponding aspartate  
               in other hCK/EK isoforms as well as yCK are essential for enzymatic   
               activity 
 
      4.4.2 Leucine 312 was important for ethanolamine specificity of hEK1 
 
4.5 Phosphorylation and regulation of hCK/EKs by protein kinase A 
      and C 
 
      4.5.1 hCKβ phosphorylation at Ser39, Ser40 and Ser42 by PKA showed  
               marginal stimulation effect 
 
               4.5.1.1 Mimicry of PKA phosphorylation on hCK β 
 
      4.5.2 Stimulation of hEK2α activity by PKC phosphorylation 
 
      4.5.3 hCK/EKs were not phosphorylated by casein kinase II in vitro 
 
4.6 hCKα2 antiserum is highly specific for hCKα isoform and mouse CKα 
 
      4.6.1 Differential expression of hCKα in normal and tumor tissues 
 
4.7 Silencing of hCKα and β by RNAi 
 
      4.7.1 RNAi targeting of hCKα and β suggests other essential role of these  
               enzymes besides phosphatidylcholine synthesis 
 
      4.7.2 Possible mechanisms for different phenotypic effects shown by hCKα  
               and β RNAi silencing 
 
               4.7.2.1 CDP-choline dependent mechanism 
 
               4.7.2.2 CDP-choline independent mechanism: hCKα/β interaction  
                           mechanism 
 
      4.7.3 Immunofluorescence shows hCKα nuclear localization 
 
 
 
 
 
222 
 
 
223 
 
224 
 
225 
 
 
229 
 
 
229 
 
 
 
231 
 
233 
 
 
236 
 
 
239 
 
239 
 
240 
 
240 
 
242 
 
244 
 
245 
 
 
246 
 
 
247 
 
249 
 
 
250 
 
 
 
 
 
 xii 
CHAPTER 5.0 CONCLUSIONS 
 
5.1 General conclusion 
 
5.2 Future studies 
 
REFERENCES 
 
APPENDICES 
 
      Appendix A 
 
      Appendix B 
 
      Appendix C 
 
      Appendix D 
 
      Appendix E 
 
      Appendix F 
 
      Appendix G 
 
      Appendix H 
 
      Appendix I 
 
      Appendix J 
 
      Appendix K 
 
      Appendix L 
 
LIST OF PUBLICATIONS 
252 
 
252 
 
256 
 
258 
 
 
 
287 
 
288 
 
289 
 
290 
 
291 
 
292 
 
293 
 
294 
 
295 
 
296 
 
297 
 
298 
 
299 
 
 xiii 
LIST OF TABLES 
 
 
 
Table 1.1 
 
 
Table 1.2 
 
Table 1.3 
 
 
Table 1.4 
 
Table 2.1 
 
Table 2.2 
 
Table 2.3 
 
Table 2.4 
 
Table 2.5 
 
Table 2.6 
 
 
 
Table 2.7 
 
Table 2.8 
 
 
Table 3.1 
 
Table 3.2 
 
 
Table 3.3 
 
 
Table 3.4 
 
 
Table 3.5 
 
 
 
Major classes of phosphoglycerides. R1 and R2 represent the 
two ester linked fatty acid chains 
 
Phospholipid composition of membranes 
 
Characteristic parameters of CK obtained with highly purified or 
recombinant enzyme preparations 
 
Cloned CK and EK from various organisms 
 
Escherichia coli strains 
 
Plasmids 
 
Oligonucleotide primers 
 
siRNA sequences and targets 
 
Software used in this work 
 
Preparation of SDS-PAGE gel containing acrylamide 
concentrations of 12% (w/v) for the separating gel and 5% (w/v) 
for the stacking gel 
 
Dilutions and sources of antibodies 
 
Nomenclatures of human and yeasts choline/ethanolamine 
kinase isoforms 
 
Molecular characteristics of human and yeast CK/EKs 
 
Catalytic rates (kcat) and catalytic efficiencies (kcat/Km) of human 
and yeast CK/EKs 
 
Relative activity of hCKα2, hCKβ, ∆89N-hEK1 and yCK mutant 
constructs compared to their respective wildtype proteins 
 
Prediction of phosphorylation sites by NetPhosK 1.0 and 
ScanProsite programs 
 
Prediction of hCKα1 and α2 subcellular localization by PSORT II 
program 
Page 
 
3 
 
 
4 
 
19 
 
 
21 
 
47 
 
49 
 
51 
 
55 
 
58 
 
67 
 
 
 
69 
 
81 
 
 
125 
 
141 
 
 
153 
 
 
163 
 
 
204 
 
 xiv 
LIST OF FIGURES 
 
 
 
Figure 1.1 
 
Figure 1.2 
 
Figure 1.3 
 
Figure 1.4 
 
 
 
Figure 1.5 
 
Figure 1.6 
 
 
Figure 1.7 
 
 
Figure 1.8 
 
 
Figure 2.1 
 
 
Figure 2.2 
 
 
Figure 2.3 
 
 
Figure 3.1 
 
 
Figure 3.2 
 
 
Figure 3.3 
 
Figure 3.4 
 
Figure 3.5 
 
Figure 3.6 
 
 
Figure 3.7 
 
 
Figure 3.8 
 
 
 
Structure of sn-Glycerol-3-phosphate 
 
Phosphorylation and breakdown of phosphatidylinositols 
 
Pathways for the biosynthesis of major eukaryotic phospholipids 
 
Comparison of the putative amino acid sequences of 
mammalian CK α and β isoforms and identification of highly 
conserved domains 
 
Alignment of CK and EK partial amino acid sequences 
 
Schematic drawing of the promoter regions of the mouse CKα 
and CKβ genes 
 
Structures of hemicholinium-3 (HC-3), choline, and 
ethanolamine 
 
Hypothesized reactions catalyzed by lic gene products in certain 
pathogenic bacteria and filarial nematodes 
 
Map of pGEX-RB and sequence features of region between 
GST coding sequence and multiple cloning site 
 
Map of pET14b and sequence features of region between T7 
promoter and T7 terminator 
 
Map of pMAL-K4 and sequence features of the region between 
the MBP coding sequence and the multiple cloning site 
 
Sequence variation between hCKα2 cDNA cloned in this work 
and the one reported by Hosaka et al. (1992) 
 
Intron-Exon organization, alternative splicing and cDNA 
structure of the gene encoding hEK2α and β 
 
Alternative splice sites for hEK2α and β in exon VII 
 
Amino acid sequence alignment of human CK/EK isoforms 
 
Amino acid sequence alignment of yeast CK/EKs 
 
Effect of temperature on the activity of hCKα1, hCKα2, hCKβ, 
∆89N-hEK1 and hEK2α 
 
Effect of pH on the activity of hCKα1, hCKα2, hCKβ, ∆89N-hEK1 
and hEK2α with choline or ethanolamine as substrate 
 
Effect of choline concentration on the activity of hCKα1, hCKα2 
and hCKβ 
Page 
 
2 
 
10 
 
12 
 
27 
 
 
 
29 
 
32 
 
 
37 
 
 
40 
 
 
71 
 
 
74 
 
 
76 
 
 
96 
 
 
107 
 
 
109 
 
126 
 
128 
 
129 
 
 
131 
 
 
133 
 
 xv 
Figure 3.9 
 
 
Figure 3.10 
 
 
Figure 3.11 
 
 
Figure 3.12 
 
 
Figure 3.13 
 
Figure 3.14 
 
 
Figure 3.15 
 
 
Figure 3.16 
 
 
Figure 3.17 
 
 
 
Figure 3.18 
 
 
Figure 3.19 
 
 
Figure 3.20 
 
 
Figure 3.21 
 
Figure 4.1 
 
 
Figure 4.2 
 
 
Figure 4.3 
 
Figure 4.4 
Effect of ethanolamine concentration on the activity of hCKα1, 
hCKα2, hCKβ, ∆89N-hEK1 and hEK2α 
 
Effect of ATP concentration on the activity of hCKα1, hCKα2, 
hCKβ, ∆89N-hEK1 and hEK2α 
 
Effect of choline concentration on the activity of yCK, yEK, SpCK 
and AgCK 
 
Effect of ethanolamine concentration on the activity of yCK, yEK 
and SpCK 
 
Effect of ATP concentration on the activity of yCK and yEK 
 
Relative activity of hCKα1, hCKα2, hCKβ, ∆89N-hEK1 and 
hEK2α with different NTPs and dNTPs 
 
Relative activity of hCKα2, hCKβ, ∆89N-hEK1 and hEK2α with 
different NTPs and dNTPs 
 
Effect of hemicholinium-3 (HC-3) concentration on the activity of 
hCKα1 and α2, hCKβ, ∆89N-hEK1 and hEK2α, yCK and yEK 
 
Amino acid sequence alignment of phosphotransferase and 
CK/EK motifs for the identification of residues critical for 
catalysis and ethanolamine specificity 
 
Effect of choline concentration on the activity of D306N, N311D 
and E349QhCKα2 constructs 
 
Effect of choline and ethanolamine concentrations on the activity 
of L312Q∆89N-hEK1 and Q308LhCKα2 constructs 
 
Effect of choline concentration on the activity of protein kinase A 
(PKA)- phosphorylated and non-phosphorylated hCKβ 
 
Relative activities of phosphoserine mimic mutants of hCKβ 
 
Amino acid sequence comparison of hCKα2, hCKβ and 
Plasmodium falciparum choline kinase (PfCK) 
 
Amino acid sequence comparison of hCK/EKs, AgCK and 
bacterial CKs 
 
Comparison of yCK and hCKβ phosphorylation sites 
 
CDP-choline pathway dependent and independent mechanisms 
as possible explanations for hCKα and β RNAi-knockdown 
phenotypes 
134 
 
 
135 
 
 
137 
 
 
138 
 
 
139 
 
145 
 
 
147 
 
 
148 
 
 
151 
 
 
 
155 
 
 
160 
 
 
176 
 
 
179 
 
228 
 
 
234 
 
 
238 
 
248 
 
 xvi 
LIST OF PLATES 
 
 
 
Plate 3.1 
 
Plate 3.2 
 
 
Plate 3.3 
 
Plate 3.4 
 
 
Plate 3.5 
 
 
Plate 3.6 
 
Plate 3.7 
 
Plate 3.8 
 
Plate 3.9 
 
 
Plate 3.10 
 
Plate 3.11 
 
 
Plate 3.12 
 
Plate 3.13 
 
Plate 3.14 
 
Plate 3.15 
 
Plate 3.16 
 
Plate 3.17 
 
 
Plate 3.18 
 
Plate 3.19 
 
Plate 3.20 
 
Plate 3.21 
 
 
 
 
 
Purification profile of hCKα2 
 
Purification profile of hCKα1. pGexRB-hCKα1 was induced in 
C41 strain with 0.3 mM IPTG at 25°C for overnight 
 
Purification profile of hCKβ 
 
Induction of pGexRB-hEK1 in C41 strain with 0.3, 0.5, 1.0 and 
2.0 mM IPTG 
 
Induction of pGexRB-hEK1 in C41, Codon+, RP, RIL and pLysS 
E. coli strains 
 
Induction of His-tag and MBP-tag hEK1 
 
Purification profile of ∆89N-hEK1 
 
Purification profile of hEK2α 
 
3’-end of hEK2α and β isoforms amplifed by primer pair 
WC171/WC57 from human cDNA library 
 
Purification profile of hEK2β 
 
Purified hEK2α and hEK2β isoforms showing their association 
with an unknown ~63 kDa protein 
 
Purification profile of His-tag hEK2β 
 
Purification profile of MBP-tag hEK2β 
 
Purified hEK2β from RP and RIL E. coli strains 
 
Purification profile of yCK 
 
Purification profile of yEK 
 
Partially purified SpCK from two different C41 clones harboring 
pGexRB-SpCK plasmid 
 
Purification profile of AgCK 
 
Purified W344AhEK2α and partially purified ∆46C-hEK2α 
 
Purified hCKα2 mutant constructs 
 
Purified D324NhCKβ, D329N∆89N-hEK1 and D394NyCK 
mutant constructs 
 
 
Page 
 
97 
 
99 
 
 
100 
 
102 
 
 
103 
 
 
104 
 
106 
 
110 
 
112 
 
 
113 
 
114 
 
 
116 
 
117 
 
118 
 
119 
 
121 
 
122 
 
 
124 
 
143 
 
152 
 
156 
 
 
 
 xvii 
Plate 3.22 
 
 
Plate 3.23 
 
 
Plate 3.24 
 
 
Plate 3.25 
 
 
Plate 3.26 
 
 
Plate 3.27 
 
Plate 3.28 
 
 
Plate 3.29 
 
Plate 3.30 
 
 
Plate 3.31 
 
 
Plate 3.32 
 
Plate 3.33 
 
 
Plate 3.34 
 
 
 
Plate 3.35 
 
 
Plate 3.36 
 
 
Plate 3.37 
 
Plate 3.38 
 
 
Plate 3.39 
 
 
Plate 3.40 
 
Purified L312Q and F327L mutant constructs of ∆89N-hEK1 and 
purified Q308LhCKα2 
 
Isotopic kinase activity assay of wildtype ∆89N-hEK1 and 
L312Q∆89N-hEK1 with choline or ethanolamine as substrate 
 
Protein kinase A-treated and non-treated yCK, hCKα2, hCKβ 
and ∆89N-hEK1 
 
PKA treated hCKα1, hCKα2, hCKβ, ∆89N-hEK1, hEK2α, yCK 
and yEK 
 
Purified S42A, S39A/S42A, S40A/S42A, S39A and S40A mutant 
constructs of hCKβ 
 
PKA phosphorylation of different hCKβ constructs 
 
Protein kinase C-treated and non-treated hCKα2, hCKβ, ∆89N-
hEK1 and hEK2α 
 
Confirmation of PKC phosphorylation of hEK2α 
 
Casein kinase II treated and non-treated hCKα2, hCKβ, ∆89N-
hEK1 and hEK2α 
 
Purified S39D/S42D, S40D/S42D, S39E/S42E and S40E/S42E 
hCKβ mutant constructs 
 
Highly purified hCKα2 used for antibody production 
 
Western blot detection of varying amounts of hCKα2 purified 
protein using different dilutions of hCKα2 antiserum 
 
Western blot detection of hCKα1, hCKα2, hCKβ, ∆89N-hEK1, 
hEK2α, ∆49N-hCKα2, ∆84N-hCKα2, yCK and yEK with hCKα2 
antiserum 
 
Western blot detection of GST-tag and His-tag hCKα2 in E. coli 
crude cell extract using different dilutions of hCKα2 antiserum 
 
Western blot detection of hCKα in HeLa cell extract with different 
dilutions of hCKα2 antiserum 
 
Western blot detection of mouse CK 
 
Western blot detection of hCKα in human normal and tumor cell 
extract 
 
Western blot detection of G3PDH used as loading control by 
G3PDH antibody 
 
hCKα and β siRNA treatment of HeLa cells 
 
159 
 
 
161 
 
 
165 
 
 
166 
 
 
168 
 
 
169 
 
171 
 
 
172 
 
174 
 
 
178 
 
 
180 
 
182 
 
 
183 
 
 
 
185 
 
 
186 
 
 
188 
 
190 
 
 
191 
 
 
194 
 
 xviii 
Plate 3.41 
 
 
Plate 3.42 
 
 
Plate 3.43 
 
Plate 3.44 
 
Plate 3.45 
Treatment of HeLa cells with different combination ratios of 
hCKα and β siRNAs 
 
Western detection of hCKα in HeLa cells treated with hCKα/β, β 
and α siRNAs, 24 and 48 hours after transfection 
 
Immunofluorescence detection of hCKα 
 
Semi-quantitative RT-PCR of hCKβ 
 
Nuclear localization of hCKα 
197 
 
 
198 
 
 
200 
 
201 
 
203 
 
 xix 
LIST OF ABBREVIATIONS 
 
 
 
APS  Ammonium persulphate 
bp  Base pair 
BSA  Bovine serum albumin 
C-  Carboxy- 
cDNA  Complementary DNA 
CK  Choline kinase 
CL  Cardiolipin 
DEPC  Diethylpyrocarbonate 
DMEM  Dulbecco’s modified Eagle’s medium 
DMSO  Dimethylsulfoxide 
DNA  Deoxyribonucleic acid 
DTT  Dithiothreitol 
ECL  Enhanced chemiluminescence 
EDTA  Ethylenediaminetetraacetic acid 
EK  Ethanolamine kinase 
FCS  Fetal calf serum 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 
GST  Glutathione sulfur transferase 
HC-3  Hemicholinium-3 
HPLC  High performance liquid chromatography 
HRP  Horse radish peroxidase 
IgG  Immunoglobulin G 
IPTG  Isopropyl-β-D-thiogalactopyranoside 
kDa  Kilo Dalton 
LB  Luria-Bertani 
LDH  Lactate dehydrogenase 
 xx 
MBP  Maltose binding protein 
MCS  Multiple cloning site 
mRNA  Messenger RNA 
Mw  Relative molecular weight 
N-  Amino- 
NADH  Nicotinamide adenine dinucleotide 
OD  Optical density 
PA  Phosphatidic acid 
PAGE  Polyacrylamide gel electrophoresis 
PBS  Phosphate buffered saline 
PC  Phosphatidylcholine 
PCho  Phosphocholine 
PE  Phosphatidylethanolamine 
PEtn  Phosphoethanolamine 
PCR  Polymerase chain reaction 
PEG  Polyethylene glycol 
PG  Phosphatidylglycerol 
PI  Phosphatidylinositol 
PK  Pyruvate kinase 
PMSF  Phenylmethylsulfonyl fluoride 
PS  Phosphatidylserine 
RNA  Ribonucleic acid 
RT-PCR Reverse transcription-polymerase chain reaction 
SDS  Sodium dodecyl sulphate 
siRNA  Small interference RNA 
SM  Sphingomyelin 
TAE  Tris-acetate-EDTA 
TEMED N,N,N’,N’-tetramethyl-ethylenediamine 
 xxi 
Tm  Melting temperature 
Tris  Tris(hydroxymethyl)-aminomethane 
U  Unit 
v/v  Volume to volume 
w/v  Weight to volume 
x g  -fold gravity 
 
Amino acids, nucleotides and deoxynucleotides are abbreviated according to the 
International Union of Pure and Applied Chemistry (IUPAC). 
 xxii 
PENCIRIAN BIOKIMIA KOLINA KINASE DAN ETANOLAMINA KINASE DARIPADA 
MANUSIA DAN YIS 
 
ABSTRAK 
 
Kolina kinase (CK) dan etanolamina kinase (EK) merupakan enzim pertama di dalam 
biosintesis fosfatidilkolina dan fosfatidiletanolamina. Peningkatan aktiviti CK telah 
dikaitkan dengan tumor manusia. Oleh itu, perencatan CK telah dicadangkan sebagai 
strategi antikanser yang berpotensi. EK pula dicadangkan penting di dalam 
karsinogenesis dengan menggalakkan pertumbuhan sel. Kajian ini melaporkan 
pengklonan gen CK/EK dan pencirian biokimia kesemua isoform CK/EK manusia. 
Sejumlah enam gen CK/EK manusia (hCKα1, hCKα2, hCKβ, hEK1, hEK2α dan 
hEK2β) telah diklon daripada perpustakaan cDNA hati dan telah diekspreskan di dalam 
Escherichia coli. CK ditunjukkan berupaya memfosforilasi kolina dan etanolamina 
tetapi EK adalah spesifik terhadap etanolamina. Perbezaan panjang yang hanya 18 
amino asid di antara hCKα1 dan α2 telah menyebabkan aktiviti isoform α1 50% lebih 
rendah. Yang menariknya, isoform hEK2β didapati tidak menunjukkan sebarang aktiviti 
enzim. Selain daripada enzim manusia, empat gen CK/EK daripada yis (yCK dan yEK 
daripada Saccharomyces cerevisiae, SpCK daripada Schizosaccharomyces pombe, 
dan AgCK daripada Ashbya gossypii) juga telah diklon, diekspreskan dan diciri secara 
biokimia. Tidak seperti homolog manusia, yEK didapati tidak spesifik terhadap 
etanolamina manakala AgCK pula mempunyai kespesifikan yang tinggi terhadap 
kolina. Kajian perencatan terhadap hCK/EK dan yCK mendedahkan bahawa 
hemikolinium-3 (HC-3) hanya efektif di dalam perencatan aktiviti isoform hCKα2 dan 
yCK bukan merupakan enzim model yang baik untuk digunakan bagi menguji 
keberkesanan perencat-perencat hCK. Kajian mutagenesis telah mengenalpasti satu 
residu aspartat yang kritikal untuk tindakbalas pemangkinan pada CK/EK manusia dan 
 xxiii 
yis. Residu penting untuk pemilihan kolina atau etanolamina sebagai substrat juga 
telah dikenalpasti. Eksperiman pemfosforilan menunjukkan bahawa hCKβ dan hEK2α 
boleh difosforilasikan oleh PKA dan PKC secara in vitro. Fosforilasi ini menyebabkan 
peningkatan sebanyak 1.5 dan 2.7 kali ganda aktiviti hCKβ dan hEK2α. Kajian ini juga 
telah menunjukkan penggunaan teknik gangguan RNA untuk menyelidik peranan 
hCKα dan hCKβ di dalam sel HeLa. ’’Knockdown’’ tunggal hCKα menyebabkan fenotip 
kematian manakala ’’knockdown’’ tunggal hCKβ tidak menunjukkan sebarang kesan 
jelas terhadap sel. Yang paling menarik, ’’knockdown’’ serentak kedua-dua isoform 
tersebut membolehkan sel tumbuh secara normal. Pemerhatian ini mencadangkan 
bahawa interaksi di antara hCKα dan β adalah penting untuk kemandirian sel. 
 xxiv 
BIOCHEMICAL CHARACTERIZATION OF HUMAN AND YEAST CHOLINE AND 
ETHANOLAMINE KINASES 
 
ABSTRACT 
 
Choline kinase (CK) and ethanolamine kinase (EK) are the first enzymes in the 
biosynthesis of phosphatidylcholine and phosphatidylethanolamine. Increased activity 
of CK has been implicated in human tumors. CK inhibition has therefore been 
proposed as a potential anticancer strategy. Likewise, EK is suggested to be important 
in carcinogenesis by promoting cell growth. This study reports the cloning of CK/EK 
cDNAs and biochemical characterization of the full set of human CK/EK isoforms. A 
total of six human CK/EKs homologs (hCKα1, hCKα2, hCKβ, hEK1, hEK2α and 
hEK2β) were cloned from liver cDNA library and expressed in Escherichia coli. CKs 
were shown to phosphorylate choline and ethanolamine, but EKs were specific for 
ethanolamine. The length difference of only 18 amino acids between hCKα1 and α2 
resulted in more than 50% lower activity in the α1 isoform. Intriguingly, the hEK2β 
isoform did not show any detectable enzyme activity. Besides the human enzymes, 
four CK/EK genes from three yeast species (yCK and yEK from Saccharomyces 
cerevisiae, SpCK from Schizosaccharomyces pombe, and AgCK from Ashbya 
gossypii) were also cloned, overexpressed and their products were biochemically 
characterized. Unlike their human homologs, yEK was not specific for ethanolamine 
while AgCK was highly specific for choline. Inhibition studies on hCK/EKs and yCK 
revealed that hemicholinium-3 (HC-3) was only effective in inhibiting the activity of the 
hCKα2 isoform and that yCK was not a good model enzyme for testing the efficacy of 
hCK inhibitors. Mutagenesis studies have identified a single aspartate residue that was 
critical for catalysis in human and yeast CK/EKs. Important residues for substrate 
preference towards either choline or ethanolamine were also identified. 
 xxv 
Phosphorylation experiments showed that hCKβ and hEK2α could be phosphorylated 
by PKA and PKC in vitro. The phosphorylations resulted in 1.5 and 2.7 fold stimulation 
of hCKβ and hEK2α activities. This work also demonstrated the use of the RNA 
interference technique to investigate the role of hCKα and β in HeLa cells. Single 
knockdown of hCKα resulted in lethal phenotype while single knockdown of hCKβ did 
not show any apparent effect on the cells. Remarkably, the  simultaneous knockdown 
of both isoforms resulted in normal cell growth. These observations suggested that the 
interaction between hCKα and β was important for cell survival. 
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CHAPTER 1.0 INTRODUCTION 
 
1.1 Phospholipids: Structures and functions 
Phospholipids are generally divided into two groups: Phosphoglycerides (also known 
as glycerophospholipids or glycerophosphatides) and sphingophospholipids (also 
known as sphingomyelins). Phospholipids generally refer to phosphoglycerides since 
sphingophospholipids are usually classified as the lipid class of sphingolipids (McKee & 
McKee, 2003). Despite their structural differences all phospholipids have hydrophobic 
and hydrophilic domains. The hydrophobic domain is composed largely of the 
hydrocarbon chains of fatty acids while the hydrophilic domain that consists of the polar 
head group, contains phosphate and other charged or polar groups (McKee & McKee, 
2003). 
 
All phosphoglycerides are derived from sn-Glycerol-3-phosphate (Figure 1.1). 
Esterification of this alcohol with two fatty acids at positions C-1 and C-2 gives a 
phosphatidate. Formation of phosphate diester linkage at position C-3 to certain 
alcohols results in different phosphoglycerides as shown in Table 1.1. The 
phosphoglycerides are named and classified according to the nature of the alcohol 
esterifying the glycerol phosphate. In most phosphoglycerides, the fatty acid 
substituted on C-1 is saturated and that on C-2 is unsaturated (Kuchel & Ralston, 
1998). It must be noted that about 1% of the total phosphoglycerides that occur in 
animal cells are in the form of lysophosphoglycerides, in which one of the acyl 
substituents, usually from C-2, is missing (Kuchel & Ralston, 1998). The 
lysophosphoglycerides are named by adding the prefix lyso- to the name of the parent 
phosphoglyceride. 
 
Phospholipids have the most important function in living organisms by forming major 
structural   components  of  membranes. Table  1.2  shows  the  lipid   compositions  of 
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Figure 1.1: Structure of sn-Glycerol-3-phosphate. Numbers indicate carbon positions 
(Metzler & Metzler, 2001). 
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Table 1.1: Major classes of phosphoglycerides. R1 and R2 represent the two ester 
linked fatty acid chains. Table adapted from McKee & McKee (2003). 
 
 
 
 
 
  X Substituent 
 
Name of X-OH  Formula of X     Name of Phospholipid 
 
 
Water        Phosphatidic acid (PA) 
 
 
Choline       Phosphatidylcholine (PC) 
 
 
Ethanolamine         Phosphatidylethanolamine 
(PE) 
 
 
 
 
Serine        Phosphatidylserine (PS) 
 
 
 
 
Glycerol       Phosphatidylglycerol (PG) 
 
 
 
 
 
Phosphatidylglycerol      Diphosphatidylglycerol 
or cardiolipin (CL) 
 
 
 
 
 
 
Inositol        Phosphatidylinositol (PI) 
 
 
 
 
 
 
 
 4 
Table 1.2: Phospholipid composition of membranes. PC, Phosphatidylcholine; PE, 
Phosphatidylethanolamine; PI, Phosphatidylinositol; PS, Phosphatidylserine; PG, 
Phosphatidylglycerol; CL, Cardiolipin (Diphosphatidylglycerol); SM, Sphingomyelin. 
Sources: Adapted from Metzler & Metzler (2001) and Zubay (1998). 
 
 
 
     Phospholipid composition (% of total lipids) 
 
Source    PC    PE     PI      PS       PG        CL        SM 
 
Rat liver 
 
  Plasma membrane  18     11      4        9         -          -           14 
 
  Rough endoplasmic 
  reticulum   55     16         8            3         -          -             3 
 
  Inner mitochondrial 
  membrane   45     25      6        1         2          18 3 
 
  Nuclear membrane  55     20      7        3          -           -  3 
 
  Golgi    40     15      6        4          -           -            10 
 
  Lysosomes   25     13      7        -          -           5           24 
 
Rat brain myelin  11     14      -        7          -           -              6 
 
Rat erythrocyte  31     15      2        7          -           -   9 
 
Human erythrocyte  17     16      1        1          -           -            16 
 
E. coli plasma membrane  0     80      -        -         15          5  - 
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different membranes and organisms. Phosphoglycerides are the most abundant 
phospholipids found in the cell membrane (McKee & McKee, 2003). Several 
phospholipids also act as emulsifying agents and surface active agents (Kuroki & 
Voelker, 1994). Phospholipids are suited to these roles because of their amphipathic 
properties (Metzler & Metzler, 2001). Interest in phospholipid metabolism has also 
blossomed in the past 15 years or so with the discovery of phospholipids being 
involved in key regulatory functions in mammalian cells (Vance & Vance, 2004). In the 
nucleus, phospholipids are important components of chromatin and they also serve as 
a pool for intranuclear signaling molecules (Albi & Viola Magni, 2004). 
 
1.1.1 Phosphatidic acid 
Phosphatidic acid (PA) is the simplest phosphoglyceride and is not an abundant lipid 
constituent in living organisms. The most important role of phosphatidic acid is acting 
as precursor for the synthesis of all other phosphoglycerides (Zubay, 1998). 
Dephosphorylation of phosphatidic acid by phosphatidate phosphatase yields 
diacylglycerol, which is a precursor for the synthesis of phosphatidylcholine and 
phosphatidylethanolamine via the Kennedy pathway. Diacylglycerol can also be further 
acylated to form triacylglycerol (Athenstaedt & Daum, 1999). It is also widely accepted 
that the primary role of diacylglycerol is to activate protein kinase C (PKC) which 
phosphorylates a range of cellular proteins (Nishizuka, 1986). 
 
1.1.2 Phosphatidylcholine 
Phosphatidylcholine (PC) is also known as lecithin. It is the most abundant 
phospholipid in animal and plants, often amounting to almost 50% of the total 
phospholipid content as it is the key building block of membrane bilayers (Billah & 
Anthes, 1990). Although PC is considered to be less characteristic of bacterial cell 
membranes, a recent estimate suggests that probably more than 10% of all bacteria 
contain PC as a membrane phospholipid (Sohlenkamp et al., 2003). In mammals, PC 
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is also the principal phospholipid in bile, lung surfactant, and plasma lipoproteins, and 
plays a critical role as second messenger in signal transduction (Vance, 2002). PC 
serves as a phospholipid pool for signaling molecules such as diacylglycerol and 
phosphatidic acid, which are produced from the hydrolysis of PC by phospholipase C 
and phospholipase D, respectively (Billah & Anthes, 1990). 
 
Perturbation of PC homeostasis has been implicated in cell death either by necrosis or 
apoptosis (Cui & Houweling, 2002). Evidence that reduction of PC synthesis alone can 
trigger apoptosis was first found in a cell line having a temperature-sensitive defect in 
phosphocholine cytidyltransferase, the second enzyme in PC synthesis via the CDP-
choline pathway (Cui et al., 1996). Edelfosine, an antitumor PC analog, has been 
demonstrated to inhibit PC synthesis, and this correlated with inhibition of cell growth in 
various cancer cell lines (Wright et al., 2004). 
 
PC is the major storage form for choline inside the brain. Choline acetyltransferase 
synthesizes the cholinergic neurotransmitter acetylcholine, from choline (Lee et al., 
1993). Coupling between phosphatidylcholine hydrolysis and acetylcholine synthesis in 
the brain has been proposed (Blusztajn et al., 1987). 
 
1.1.3 Phosphatidylethanolamine 
Phosphatidylethanolamine (PE) is the major phospholipid in bacterial membranes and 
the second most abundant phospholipid in eukaryotes (Mazzella et al., 2004). PE is 
also known as cephalin (McKee & McKee, 2003). Unlike other eukaryotic cell 
membranes, Drosophila’s major phospholipid is PE instead of PC, with PE comprising 
about 55% of the total membrane phospholipids (Jones et al., 1992). In liver and yeast, 
PE serves as precursor for the synthesis of PC by phosphatidylethanolamine N-
methyltransferase (PEMT) pathway (Carman & Henry, 1999; Noga & Vance, 2003). PE 
is also involved in the direct post-translational modification of proteins to allow their 
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association with membranes. Thus, it was shown that the yeast protein Apg8p, an 
essential factor for autophagy, is reversibly modified with PE (Kirisako et al., 2000). 
The amount of PE within the lipid bilayer determines membrane structure and fluidity 
(Yeagle, 1989). 
 
1.1.4 Phosphatidylserine 
Phosphatidylserine (PS) is the only amino acid containing phosphoglyceride. Although 
it is widely distributed in animals, plants and microorganisms, it usually represents less 
than 10% of the total phospholipids. PS is located entirely on the inner monolayer 
surface of the plasma membrane and other cellular membranes (Manno et al., 2002). 
This distribution is disturbed during platelet activation and cellular apoptosis (Martinez 
et al., 2006). PS is known to externalize to the cell surface in apoptotic cells and 
believed to be important for the recognition and removal of apoptotic cells by 
phagocytes (Yoshida et al., 2005); it also serves as important cofactor for the activation 
of protein kinase C and other enzymes such as Na+/K+ ATPase and neutral 
sphingomyelinase, and is involved in the blood coagulation process in platelets (Lentz, 
2003). 
 
1.1.5 Phosphatidylglycerol 
Phosphatidylglycerol (PG) is the main component of some bacterial membranes, for 
example, E. coli has up to 20% of PG in its membrane (Mazzella et al., 2004). In 
plants, PG is required for photosynthetic function in the thylakoid membrane (Sato et 
al., 2000); it is especially important as a component of the lung surfactant in animals 
(Hallman & Gluck, 1976). Moreover, PG has been reported to function as precursor for 
the biosynthesis of the poly(glycerol phosphate) backbone of lipoteichoic acid in 
bifidobacteria (Op den Camp et al., 1985). 
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1.1.6 Diphosphatidylglycerol 
Diphosphatidylglycerol, also known as cardiolipin (CL), is found almost exclusively in 
energy transducing membranes such as the bacterial cytoplasmic membrane and the 
inner membrane of mitochondria (Wright et al., 2004). The content of CL in the 
membrane becomes a critical factor for mitochondrial function under different stress 
conditions such as temperature changes, low substrate level and oxidative stress 
(Schlame et al., 2000). Interaction of CL with a large number of mitochondrial proteins 
can lead to functional activation of certain enzymes, especially those involved in 
oxidative phosphorylation (Schlame et al., 2000). CL may also have a specific role in 
the import of proteins into mitochondria and regulation of gene expression (Wright et 
al., 2004). 
 
CL is thought to play a decisive role in apoptosis by the recruitment of cytosolic 
proteins to mitochondria and membrane permeabilization for the concomitant release 
of apoptogenic mitochondrial proteins (Wright et al., 2004). Thus, it has been 
demonstrated to be tightly associated with cytochrome c. Since release of cytochrome 
c into the cytoplasm is a major regulatory event during the induction of apoptosis, this  
is a rate limiting step in the formation of apoptosome for activation of executioner 
caspases (Wright et al., 2004). 
 
1.1.7 Inositol-containing phospholipids 
Inositol-containing phospholipids are generally known as phosphoinositides; they 
constitute 2 to 8 % of the lipids in eukaryotic cell membranes but are metabolized more 
rapidly than other lipids (Majerus et al., 1988). Animal cells contain three distinct 
species of inositol-containing phospholipids, the most abundant being 
phosphatidylinositol (PI). PI can be sequentially phosphorylated by specific kinases 
leading to the production of phosphatidylinositol-4-phosphate (PIP) and 
phosphatidylinositol-4,5-biphosphate (PIP2), by addition of phosphate groups to 
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hydroxyl residues in the inositol ring as shown in Figure 1.2 (Campbell & Smith, 2000). 
The release of inositol-1,4,5-triphosphate and diacylglycerol from PIP2 is  catalyzed by 
phospholipase C (Figure 1.2). Inositol-1,4,5-triphosphate is a signaling molecule that 
promotes the release of intracellular calcium, and diacyglycerol is a signaling molecule 
that activates several isoforms of protein kinase C (Berridge & Irvine, 1984). 
 
1.1.8 Sphingophospholipids 
Sphingophospholipids, also known as sphingomyelin (SM), are primary phospholipids 
in brain (10% of total phospholipid) and erythrocytes of ruminant animals, but it does 
not appear to occur in plants or microorganisms (Zubay, 1998). In a single cell, SM is 
present in higher percentage in the nucleus compared to other phospholipids and its 
amount changes in different cell physiological states (Albi & Viola Magni, 2004). SM is 
hypothesized to play a role in RNA maturation by protecting part of the RNA from 
enzyme digestion prior to exportation from the nucleus (Albi & Viola Magni, 2004). SM 
may also act to stabilize DNA as a decrease in SM concentration during S-phase was 
reported to favor the unwinding of DNA (Albi et al., 1997; Albi & Viola Magni, 2004). SM 
and cholesterol may be located together in specific sub-domains of membranes to form 
lipid rafts, which have been associated with cellular signalling, virus trafficking, 
intracellular transport, and budding of yeasts (van Meer & Lisman, 2002). The 
importance of SM in signal transduction is also linked to the action of sphingomyelinase 
on SM to form ceramide, a widely known second messenger for many pathways 
including apoptosis (Pettus et al., 2002). 
 
1.2 Biosynthesis of major eukaryotic membrane phospholipids: Phosphatidic 
acid, phosphatidylethanolamine, phosphatidylcholine and phosphatidylserine 
Eukaryotic cell membranes contain more than a thousand different phospholipid 
species as a result of the diverse mixture of acyl chains at the sn-1 and sn-2 positions 
and  the  variety  of  polar  head  groups  (Vance & Vance, 2004). Studies of eukaryotic 
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Figure 1.2: Phosphorylation and breakdown of phosphatidylinositols. 
Phosphatidylinositol (PtdIns) can be successively phosphorylated on positions 4 and 5 
of the inositol ring to give phosphatidylinositol 4-phosphate (PIP) and 
phosphatidylinositol 4,5-biphosphate (PIP2). The release of diacylglycerol (DAG) and 
phosphorylated inositol derivatives, such as inositol 1,4,5-triphosphate (InsP3) that 
function in cell signaling, is catalyzed by specific phospholipase C (PLC). Figure  
adapted from Campbell & Smith (2000). 
DAG 
PtdIns PIP PIP2 InsP3 
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phospholipid biosynthesis have a long history, dating back to the 1950s when most of 
the pathways were delineated, mostly by Eugene Kennedy’s work (Kent, 1995). 
Identification of the genes and gene products involved in the biosynthesis of major 
phospholipids were slow due to difficulties encountered in purifying the respective 
enzymes as many of them are membrane-associated (Kent, 1995; Vance & Vance, 
2004). Nevertheless, most of the genes involved in the biosynthetic pathways of 
phospholipids have been identified. 
 
1.2.1 Synthesis of the backbone, phosphatidic acid 
For the synthesis of PA, glycerol-3-phosphate is first converted into 1-acylglycerol-3-
phosphate (lysophosphatidate) by glycerol-3-phosphate acyl-transferase (Figure 1.3). 
Two isoforms of this enzyme, which are encoded by two separate genes and have 
distinct subcellular localization have been identified (Vance & Vance, 2004). The 
second acylation step is catalyzed by acyltransferase, the donor of fatty acyl chains of 
phosphatidate is acyl-CoA. Five different acyl-CoA synthetases have been identified, 
they differ in their subcellular localization and acyl chain preference (Vance & Vance, 
2004). 
 
PA can be hydrolyzed by phosphatidate phosphatase to yield diacylglycerol, or 
converted to CDP-diacylglycerol by CDP-diacylglycerol synthase (Figure 1.3). 
Diacyglycerol is required for the synthesis of PC, PE and PS. CDP-diacylglycerol is 
used for the synthesis of PI, PG and CL. Cloning of mouse and human phosphatidate 
phosphatase cDNAs have been reported (Kai et al., 1996; Sun et al., 2005). Two 
genes encoding human CDP-diacylglycerol synthase have also been reported and the 
two isoforms are believed to have different cellular localization according to their 
functions (Vance & Vance, 2004). 
 
 
 12
CDP-Choline Pathway         CDP-Ethanolamine Pathway 
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Figure 1.3: Pathways for the biosynthesis of major eukaryotic phospholipids (Kent & 
Carman, 1999; Zubay, 1998). Enzyme involved in individual steps are boxed. CK, choline 
kinase; EK, ethanolamine kinase; CCT, choline phosphate cytidyltransferase; ECT, 
ethanolamine phosphate cytidyltransferase; CPT, choline phosphotransferase; EPT, 
ethanolamine phosphotransferase; GPAT, glycerol-3-phosphate acyltransferase; 1 acyl-
GPAT, acyltransferase; PAC, phosphatidate cytidyltransferase; PSS, phosphatidylserine 
synthase; PSD, phosphatidylserine decarboxylase; PEMT, phosphatidylethanolamine N-
methyltransferase; PIS, phosphatidylinositol synthase; PG-P synthase, 
phosphatidylglycerol phosphate synthase; PG-P phosphatase, phosphatidylglycerol 
phosphate phosphatase; CL synthase, cardiolipin or diphosphatidylglycerol synthase; PA, 
phosphatidic acid; PS, phosphatidylserine; PC, phosphatidylcholine; PE, 
phosphatidylethanolamine; PME, phosphatidylmonoethanolamine ; PDE, 
phosphatidyldiethanolamine; PI, phosphatidylinositol; PG, phosphatidylglycerol; CL, 
cardiolipin (diphosphatidylglycerol); DAG, diacylglycerol; AdoMet, S-adenosylmethionine; 
AdoHcy, adenosylhomocystein. Conversion of PC or PE to PS by base exchange reaction 
Glycerol-3-phosphate 
1-acylglycerol-
3-phosphate 
acyl-CoA 
acyl-CoA 
CoA 
CoA 
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1.2.2 Synthesis of phosphatidylcholine 
Generally, there are two pathways for PC biosynthesis (Figure 1.3), namely the CDP-
choline pathway and the PE methylation pathway. The PE methylation pathway 
predominates in yeast (Kent, 1995) and mammalian liver cells, whereas the CDP-
choline pathway is predominant in other mammalian cells (DeLong et al., 1999). The 
CDP-choline pathway in yeast becomes more important when enzymes of the CDP-
diacylglycerol pathway are defective or repressed (Carman & Henry, 1989). The yeast 
CDP-choline pathway also acts as salvage pathway for choline that resulted from 
turnover of PC synthesized by CDP-diacylglycerol pathway (McMaster & Bell, 1994a). 
In fact, mutants defective in CDP-choline pathway enzymes, such as choline kinase, 
excrete choline into the growth medium as a result of PC turnover and their inability to 
reutilize choline for PC synthesis by the CDP-choline pathway (Patton-Vogt et al., 
1997). PC synthesized by CDP-choline and CDP-diacylglycerol may have distinct as 
well as overlapping functions in cell physiology (Carman & Kersting, 2004). 
 
In prokaryotes, PC biosynthesis was thought to occur only by PE methylation, however, 
a second pathway for PC biosynthesis that is distinct from CDP-choline pathway and 
seems to be exclusive to bacteria, known as the phosphatidylcholine synthase (PCS) 
pathway, has recently been discovered (Sohlenkamp et al., 2000). In this pathway, 
choline is condensed directly with CDP-diacylglycerol to form PC and CMP in a 
reaction catalysed by PCS (Martinez-Morales et al., 2003). 
 
1.2.2.1 CDP-choline pathway 
The CDP-choline pathway (Figure 1.3) was first described by Eugene Kennedy who 
discovered that CTP, rather than ATP, was the activating nucleotide for this 
biosynthetic pathway (Kennedy & Weiss, 1956). The committed step in the synthesis of 
PC is catalyzed by choline kinase that phosphorylates choline to form phosphocholine 
with ATP as the phosphoryl donor. CTP:phosphocholine cytidyltransferase 
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subsequently converts phosphocholine into CDP-choline with CTP. The final step in the 
CDP-choline pathway is catalyzed by choline phosphotransferase that catalyzes the 
formation of PC from CDP-choline and diacylglycerol (Carman & Henry, 1999; Kent, 
1995; Vance & Vance, 2004). Under normal metabolic conditions, the CDP-choline 
pathway is regulated by the second enzyme in the pathway, CTP:phosphocholine 
cytidyltransferase (Vance & Vance, 2004). However, the first enzyme in this pathway, 
choline kinase can also be regulatory at choline concentration higher than 100 µM 
(McMaster & Bell, 1994b). 
 
Since choline is not synthesized de novo in animal cells, this important PC precursor 
has to come from the diet, or must be added to cell culture medium. Two classes of 
transporter have been proposed for choline transport into cells (Ishidate, 1997). The 
first type of transporter is a high affinity sodium-dependent transporter (Yamamura & 
Snyder, 1972), whereas the second type is a low affinity sodium-independent 
transporter (Ferguson et al., 1991). 
 
1.2.2.2 Phosphatidylethanolamine methylation pathway 
The phospholipid N-methyltransferases catalyze the three step AdoMet-dependent 
methylation of PE to PC as shown in Figure 1.3 (Carman & Henry, 1999). In yeast, the 
first methylation reaction is catalyzed by the PE methyltransferase (Kodaki & 
Yamashita, 1987), and the last two methylation reactions are catalyzed by phospholipid 
methyltransferase (Gaynor & Carman, 1990). Mammalian PE methyltransferase was 
first purified from rat liver and, unlike in yeast, this enzyme catalyzes all three 
methylation reactions of the conversion from PE to PC (Ridgway & Vance, 1988). 
 
1.2.3 Synthesis of phosphatidylethanolamine 
The two major biosynthetic pathways of PE are the CDP-ethanolamine pathway as 
originally described by Kennedy and Weis (1956) and the PS decarboxylation pathway 
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(Vance & Vance, 2004). A small amount of PE can also be synthesized by base-
exchange reaction as catalyzed by PS synthase-2 (Sundler et al., 1974). The 
importance of the CDP-ethanolamine pathway and of the PS decarboxylation pathway 
are cell type-dependent. Typically, BHK (Voelker, 1984) and CHO cell lines (Miller & 
Kent, 1986) have more than 80% of their PE synthesized through the PS 
decarboxylation pathway even when the cells are supplied with sufficient ethanolamine 
to support PE synthesis via the CDP-ethanolamine pathway. In contrast, the CDP-
choline pathway has been reported to be the prominent PE synthesis pathway in rat 
liver and hepatocytes as well as hamster heart (Vance & Vance, 2004). 
 
1.2.3.1 CDP-ethanolamine pathway 
The committed step in the synthesis of PE via the CDP-ethanolamine pathway (Figure 
1.3) is catalyzed by ethanolamine kinase. This enzyme phosphorylates ethanolamine 
to yield phosphoethanolamine, using ATP as phosphoryl donor. The second step is 
catalyzed by CTP:phosphoethanolamine cytidyltransferase which catalyzes the 
formation of CDP-ethanolamine from CTP and phosphoethanolamine. As in the parallel 
CDP-choline pathway, this step is believed to be the rate limiting step in the CDP-
ethanolamine pathway. The last step in the CDP-ethanolamine pathway is catalyzed by 
ethanolamine phosphotransferase that catalyzes the formation of PE from CDP-
ethanolamine and diacylglycerol (Kennedy & Weiss, 1956; Vance & Vance, 2004). 
 
1.2.3.2 Phosphatidylserine decarboxylation pathway 
The conversion of PS to PE is catalyzed by PS decarboxylase (Figure 1.3). There are 
two genes encoding PS decarboxylase in S. cerevisiae, PSD1 and PSD2 (Carman & 
Kersting, 2004). The PSD1-encoded enzyme is responsible for more than 90% of the 
PS decarboxylase activity in yeast cells (Carman & Kersting, 2004). In contrast, all PS 
decarboxylase activity in mammalian cells appears to result from the product of a 
single gene (Kuge et al., 1991). Production of PE from decarboxylation of PS is limited 
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by the transfer of newly synthesized PS (mostly in ER) to the location of PS 
decarboxylase in the mitochondrial inner membrane (Voelker, 1989). 
 
1.2.4 Synthesis of Phosphatidylserine 
Phosphatidylserine (PS) is synthesized by phosphatidyl transfer from either CDP-
diacylglycerol (in yeast and prokaryotes) as shown in Figure 1.3, or PC/PE in 
mammalian cells (Kent, 1995; Vance & Vance, 2004). Phosphatidyl transfer from PC or 
PE is also known as base-exchange reaction (Kent, 1995). PS synthase catalyzes the 
transfer of the phosphatidyl moiety from CDP-diacylglycerol to serine. CDP-
diacylglycerol is synthesized from CTP and PA by CDP-diacylglycerol synthase (Vance 
& Vance, 2004). In the base exchange reaction, the head group of preexisting 
phospholipids (PC and PE) is replaced by L-serine (Vance, 2003). The reaction is 
catalyzed by two distinct calcium-dependent PS synthases: PS synthase 1 exchanges 
serine for the choline head group of PC, whereas PS synthase 2 uses PE (Vance & 
Vance, 2004). In fact, there may be more than two base exchange enzymes in 
mammalian cells, with enzymes in different tissues and subcellular locations exhibiting 
distinct substrate specificities and abilities to be stimulated by agonists (Siddiqui & 
Exton, 1992). 
 
1.3 Choline kinase (CK) and ethanolamine kinase (EK) 
CK (ATP:choline phosphotransferase, EC 2.7.1.32) and EK (ATP:ethanolamine 
phosphotransferase, EC 2.7.1.82) catalyze the phosphorylation of 
choline/ethanolamine by ATP in the prescence of Mg2+, yielding 
phosphocholine/phosphoethanolamine and ADP (Ishidate, 1997). These enzyme steps 
commit choline/ethanolamine to the so-called Kennedy pathway (CDP-choline or CDP-
ethanolamine pathway) for biosynthesis of PC and PE (Figure 1.3). 
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It has been a controversial issue as to whether the same enzyme catalyzes the 
phosphorylation of choline and ethanolamine since highly purified CK from rat kidney 
(Ishidate et al., 1984), liver (Porter & Kent, 1990) and brain (Uchida & Yamashita, 
1990) all showed EK activity, though with considerable preference for choline. The 
nomenclature of choline kinase therefore became choline/ethanolamine kinase 
(CK/EK). In S. cerevisiae, there are two enzymes that are able to phosphorylate 
choline and ethanolamine, and these enzymes are annotated based on their preferred 
substrate specities (Lykidis et al., 2001). The choline kinase (CKI) has 3.6 fold higher 
specific activity with choline compared to ethanolamine, whereas the ethanolamine 
kinase (EKI) has 2 fold higher specific activity with ethanolamine compared to choline 
(Kim et al., 1999). 
 
On the contrary, there have been some earlier reports which suggested the existence 
of separate EK in mammalian species (Brophy et al., 1977; Draus et al., 1990; Upreti et 
al., 1976; Weinhold & Rethy, 1974), and CK/EK activities have also been shown to be 
separable in several lower eukaryotes and plants (Ishidate, 1997; Wharfe & Harwood, 
1979). The discovery of an ethanolamine-specific kinase in Drosophila (Pavlidis et al., 
1994) has also led to the speculation that EK, which is essentially devoid of CK activity, 
may also exist in mammalian species. Only recently, a human ethanolamine specific 
kinase cDNA was cloned by Lykidis et al. (2001). In addition, the existence of 
monomethylethanolamine kinase and dimethylethanolamine kinase, which are different 
from either CK or EK, has been reported in rat brain (Cao & Kanfer, 1991). 
 
CK/EKs are ubiquitously distributed in eukaryotes from yeast to mammals and plants 
(Yamashita & Hosaka 1997). CK/EKs are generally accepted as cytosolic and can be 
handled as soluble enzymes by conventional purification procedures (Yamashita & 
Hosaka, 1997). Particularly, mammalian CK, besides its conventional role in PC 
synthesis, has also been implicated in cancer pathogenesis, and its inhibition has been 
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proposed as a promising anticancer strategy (Ramirez de Molina, 2002a). In addition, 
increased CK activity in response to treatment of rats with aromatic hydrocarbons 
(Ishidate et al., 1982), or treatment of cultured cells with growth stimulants such as 
serum, epidermal growth factors, or insulin (Uchida, 1996; Warden & Friedkin, 1985), 
has also been reported. 
 
1.3.1 Purification and substrate specificity of choline/ethanolamine kinase 
Choline kinase was first purified by Wittenberg & Kornberg (1953) with a 25-fold 
enrichment of enzyme activity from brewer’s yeast autolysate. Until another attempt to 
purify the yeast choline kinase by Brostrom & Browning (1973), the enzyme was used 
for practical purposes such as for the determination of acetylcholine in biological 
materials (McCaman et al., 1971). Partially purified yeast choline kinase was shown to 
mediate the phosphorylation of not only choline, but also N,N-dimethylethanolamine, N-
monomethylethanolamine, and ethanolamine (Wittenberg & Kornberg, 1953). The 
ability of yeast choline kinase to phosphorylate ethanolamine besides choline has 
subsequently been confirmed by gene disruption studies showing functional 
complementation (Hosaka et al. 1989) and characterization of purified recombinantly 
produced choline kinase (Kim et al., 1998). 
 
Different characteristics of choline kinases from various mammalian tissues strongly 
indicated that choline kinase does exist in several isoforms (Ishidate, 1997). This was 
subsequently confirmed by cDNA cloning of three different rat choline kinase isoforms 
(Aoyama et al., 1998b; Uchida, 1994b; Uchida & Yamashita, 1992b). It is now generally 
accepted that mammalian cells have at least three choline kinase isoforms (termed α1, 
α2, and β) and the active enzyme consists of either their homo- or hetero-dimeric (or 
oligomeric) species (Aoyama et al., 2004). Table 1.3 shows the characteristics of CKs 
obtained with enzymes that were highly purified from mammalian sources or produced 
recombinantly.   Currently,  highly  purified   ethanolamine-specific   kinases   are   still 
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Table 1.3: Characteristic parameters of CK obtained with highly purified or recombinant 
enzyme preparations. All of these highly purified CKs also showed EK activities. S.A, 
specific activity. Table is adapted from Aoyama et al. (2004). 
 
 
Source        SDS-PAGE     Native S.A  Km Choline Km ATP     Putative 
            (kDa)         form     (mmol/min/mg)        (µM)   (mM)      isoform 
 
 
Rat kidneya,b      42         dimer     3.3        100     1.5         CKβ 
 
Rat liverc   47       tetramer    143          13    0.04         CKα2 
 
Rat braind   44         dimer      40          14      1,0         CKα1 
 
S. cerevisiaee   73         dimer    128          270    0.09         CKI 
(recombinant) 
 
C. elegansf   48         dimer      43      1.6 mM      2.4         CKA-2 
(recombinant)   40      (oligomer)     2.4       13 mM    0.72         CKB-2 
 
 
a
 Ishidate et al. (1984) 
b
 Ishidate et al. (1985) 
c
 Porter & Kent (1990) 
d
 Uchida & Yamashita (1990) 
e
 Kim et al. (1998) 
f
 Gee & Kent (2003) 
 20
unavailable; only partial purification of EKs from rat liver (Uchida, 1997; Weinhold & 
Rethy, 1974) and recombinantly produced GST-tagged Drosophila EK (Uchida, 1997) 
have been reported. 
 
1.3.2 Molecular cloning of eukaryotic choline kinase 
Table 1.4 shows the cDNA cloning of CK and EKs from various organisms together 
with their nomenclatures and properties. The first CK structural gene was isolated from 
S. cerevisiae by means of genetic complementation, using a mutant defective in CK 
activity (Hosaka et al.,1989). This CK was termed CKI; no intron was present in its 
protein coding sequence. The clone had an open reading frame of 582 amino acids 
with calculated molecular size of 66,316 Da. The cloned gene could be expressed in E. 
coli and the resulting transformed cells displayed significant CK activity. The 
transformed bacteria also displayed EK activity, indicating that both activities could be 
encoded by the same gene in yeast (Hosaka et al., 1989). Subsequent expression, 
purification and characterization of yeast CK expressed in Sf-9 insect cells confirmed 
its CK activity and showed that ethanolamine was a poor substrate compared to 
choline (Kim et al., 1998). 
 
In S. cerevisiae, Sec14p is a PI/PC transfer protein that is essential for cell viability and 
vesicle budding from the Golgi complex (Fang et al., 1998). It has been proposed that 
the function of Sec14p is to down-regulate the synthesis of PC via the CDP-choline 
pathway (Fang et al., 1998). It appears that too much PC synthesized via the CDP-
choline pathway is detrimental to the secretory process (Kent & Carman, 1999). 
Interestingly, mutations in the CKI gene can suppress (bypass) the lethal phenotype of 
sec14 mutants (Cleves et al., 1991) by causing a block in the CDP-choline pathway, 
which in turn excludes the need for Sec14p function (Cleves et al., 1991; Fang et al., 
1998). 
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Table 1.4: Cloned CK and EK from various organisms. Ethanolamine specific EK from 
human and D. melanogaster are marked by *. 
 
 
Source  Nomenclature  Putative number Calculated 
     of amino acid  molecular weight (kDa) 
 
 
Rat liver CKR1(CKα1)a     435        50 
  CKR2(CKα2)a     453        52 
 
Rat kidney CKβb      394        45 
 
Mouse  CKα1c      435        50 
embryo CKα2c      453        52 
  CKβc      394        45 
 
Human hCKα2d     456        52 
glioblastoma 
 
Human liver   *EKI-1e      452        50 
  EKI-2αe     477         - 
  EKI-2βe     394         - 
 
 
S. cerevisiae CKIf      582        66 
  EKIg      534        62 
 
C. elegans CKA-2h     429        49 
  CKB-2h     369        42 
 
 
Drosophila     *dEK (eas)i     517        59 
melanogaster 
 
Soybean GmCK1j     359        41 
  GmCK2j     362        42 
  GmCK3j    >497       >56 
 
Pea  CKk      343        40 
 
 
a
 Uchida & Yamashita (1992b) 
b
 Uchida (1994b) 
c
 Aoyama et al. (1998a) 
d
 Hosaka et al. (1992) 
e
 Lykidis et al. (2001) 
f
 Hosaka et al. (1989) 
g
 Kim et al. (1999) 
h
 Gee & Kent (2003) 
i
 Monks et al. (1996) 
j
 Al-Malki et al. (2000) 
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Cloning of the first mammalian CK was reported by Uchida & Yamashita (1992b). By 
screening a rat liver cDNA expression library constructed in λgt11 with antibodies 
raised against highly purified rat liver choline kinase, an open reading frame encoding 
435 amino acids with a calculated molecular size of 49,743 Da was isolated and 
confirmed to be the structural gene of choline kinase termed CKR1 (Uchida & 
Yamashita, 1992b). This enzyme was found to mediate the phosphorylation of both 
choline and ethanolamine. Subsequently, the cDNA of a CKR1-related isoform, termed 
CKR2, was cloned by Uchida (1994b) from the same cDNA library; it contained an 
extra 54 bases internal sequence probably arising through alternative splicing. Thus, 
CKR2 is predicted to encode a protein of 453 amino acids with a molecular weight of 
51,824 Da. Southern blot analysis indicated a single copy of the CKR gene. The 
genomic DNA containing the first exon and its flanking regions was isolated and 
partially characterized (Uchida, 1994b). The CKR gene showed not only characteristics 
of a typical housekeeping gene but also of a gene regulated through a variety of 
putative cis-acting elements. The most interesting point could be an involvement of 
both the putative xenobiotic and antioxidant responsive elements in the 5’ flanking 
region of the CKR gene (Uchida, 1994b). 
 
More recently, by means of peptide sequence information of a 42 kDa (estimated by 
SDS-PAGE) choline kinase, a cDNA clone encoding 394 amino acids with a calculated 
molecular size of 45,100 kDa has been cloned from a rat kidney cDNA library. 
Significant CK and EK activities appeared in cell lysate of E. coli transfected with 
plasmid carrying this ORF (Aoyama et al., 1998b). Amino acid sequence comparison of 
this CK with previously cloned CKR1 and CKR2 showed only 57 to 59% identity, 
indicating that the cloned cDNA must be a product of a gene distinct from that for CKR 
(Aoyama et al., 1998b). Altogether, three isoforms of CKs have been cloned from rat, 
and the nomenclatures of CKR1, CKR2 and 42 kDa CK/EK were renamed by Aoyama 
et al. (2000) as CK/EKα1, CK/EKα2 and CK/EKβ, respectively. CK/EKα and CK/EKβ 
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are encoded by two distinct genes, and all three choline kinase isoforms exhibit 
significant ethanolamine kinase activity. 
 
Human CK cDNA was cloned from a glioblastoma cDNA expression library by 
complementation of the same yeast cki mutant used in cloning of S. cerevisiae CK 
(Hosaka et al., 1992). The deduced sequence of the human enzyme comprised 456 
amino acids with a calculated molecular weight of 52,065 Da. The cDNA was 
confirmed to encode CK when an E. coli expression plasmid yielded highly increased 
CK activity in bacterial cell lysate,  and when cloned into an S. cerevisiae vector it also 
managed to rescue the yeast cki mutant (Hosaka et al., 1992). Based on sequence 
identities, the human CK was identified as homolog of the rat CK/EKα2 isoform, hence, 
it was termed hCKα2 (Aoyama et al., 2000; Aoyama et al., 2004). The human homolog 
of rat CK/EKβ was identified by Yamazaki et al. (1997) while characterizing the gene 
structure of human muscle type carnitine palmitoyltransferase I (CPTI-M). Human CKβ 
(hCKβ) gene is located only about 300 bp upstream from exon 1A of the human CPTI-
M gene. The predicted cDNA sequence of hCKβ was subsequently reported by 
Aoyama et al. (2000). However, hCKβ has never been characterized and its choline 
kinase activity has yet to be confirmed. 
 
Mouse putative choline kinases, CK/EKα1 and CK/EKβ were cloned by Aoyama et al. 
(1998a) from a mouse embryo cDNA library. Amino acid sequences of both mouse 
choline kinase isoforms share high sequence identity with the respective rat CK/EKα1 
(96.0%) and CK/EKβ (92.4%). However, characterizations of both isoforms have never 
been reported. 
 
Recently, cloning and characterizations of CKs from Caenorhabditis elegans have 
been reported by Gee & Kent (2003). They cloned five and expressed four out of seven 
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genes that were found in the C. elegans genome and that are likely to encode choline 
and/or ethanolamine kinases. The proteins were expressed in Sf-9 insect cell and 
showed CK activity. Those that resemble the mammalian CKs were the most active 
ones (Gee & Kent, 2003). The most active isoform, CKA-2, was purified to near 
homogeneity; it showed similarly high catalytic activity compared to CKs from rat liver 
and yeast (Gee & Kent, 2003). Another purified and characterized isoform is CKB-2; it 
has much lower activity compared to the CKA-2 isoform (Gee & Kent, 2003). CKA-2 is 
also the first CK whose crystal structure was solved (Peisach et al., 2003). 
 
Molecular cloning of a plant CK was first reported by Monks et al. (1996) for soybean 
(Glycine max). Two distinct full length cDNAs encoding two putative CKs, designated 
GmCK1 and GmCK2, were isolated from a soybean cDNA library. Heterologous 
expression of GmCK1 in yeast (S. cerevisiae) and GmCK2 in yeast and E. coli 
confirmed that both encode active CKs (Monks et al., 1996). However, unlike the CKs 
from animals and yeast, soybean choline kinase did not show any significant EK 
activity when the cell extracts from yeast and E. coli expressing GmCK1 and GmCK2 
were assayed for ethanolamine phosphorylating activity (Monks et al., 1996). 
 
Full length cDNA from pea that encodes a putative CK protein of 343 amino acids (with 
a calculated molecular weight of 39,785 Da) has been cloned and expressed in E. coli 
(Al-Malki et al., 2000). Induced expression of the protein encoded by the pea cDNA in 
E. coli produced significant amount of CK activity in the E. coli cell extract (Al-Malki et 
al., 2000). 
 
As summarized in Table 1.3, only recombinantly produced S. cerevisiae and C. 
elegans CKs have been purified to homogeneity. Both were expressed in Sf-9 insect 
cells using the baculovirus system (Gee & Kent, 2003; Kim et al., 1998). Surprisingly 
little attention has been given to molecular cloning of different isoforms of human CK. 
